Hemodynamic effects of substance P and its receptor antagonist RP67580 in anesthetized rats with carbon tetrachloride-induced cirrhosis

References

• Groszmann RJ. Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences. Hepatology 1994; 20: 1359–63
   PubMed Web of Science ®Google Scholar
• Moller S, Bendtsen F, Henriksen JH. Vasoactive substances in the circulatory dysfunction of cirrhosis. Scand J Clin Lab Invest 2001; 61: 421–9
   PubMed Web of Science ®Google Scholar
• Thomas SH, Joh T, Benoit JN. Role of bile acids in splanchnic hemodynamic response to chronic portal hypertension. Dig Dis Sci 1991; 36: 1243–8
   PubMed Web of Science ®Google Scholar
• Silva G, Navasa M, Bosch J, Chesta J, Pilar Pizcueta M, Casamitjana R, et al. Hemodynamic effects of glucagon in portal hypertension. Hepatology 1990; 11: 668–73
   PubMed Web of Science ®Google Scholar
• Sitzmann JV, Bulkley GB, Mitchell MC, Campbell K. Role of prostacyclin in the splanchnic hyperemia contributing to portal hypertension. Ann Surg 1989; 209: 322–7
   PubMed Web of Science ®Google Scholar
• Martin PY, Gines P, Schrier RW. Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis. N Engl J Med 1998; 339: 533–41
   PubMed Web of Science ®Google Scholar
• Lee SS, Huang M, Ma Z, Rorstad O. Vasoactive intestinal peptide in cirrhotic rats: hemodynamic effects and mesenteric arterial receptor characteristics. Hepatology 1996; 23: 1174–80
   PubMed Web of Science ®Google Scholar
• Hori N, Okanoue T, Sawa Y, Kashima K. Role of calcitonin gene-related peptide in the vascular system on the development of the hyperdynamic circulation in conscious cirrhotic rats. J Hepatol 1997; 26: 1111–9
   PubMed Web of Science ®Google Scholar
• Guevara M, Gines P, Jimenez W, Sort P, Fernandez-Esparrach G, Escorsell A, et al. Increased adrenomedullin levels in cirrhosis: relationship with hemodynamic abnormalities and vasoconstrictor systems. Gastroenterology 1998; 114: 336–43
   PubMed Web of Science ®Google Scholar
• Batkai S, Jarai Z, Wagner JA, Goparaju SK, Varga K, Liu J, et al. Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis. Nat Med 2001; 7: 827–32
   PubMed Web of Science ®Google Scholar
• Delas Heras D, Fernandez J, Gines P, Cárdenas A, Ortega R, Navasa M, et al. Increased carbon monoxide production in patients with cirrhosis with and without spontaneous bacterial peritonitis. Hepatology 2003; 38: 452–9
   PubMed Web of Science ®Google Scholar
• Harrison S, Geppetti P. Substance P. Int J Biochem Cell Biol 2001; 33: 555–76
   PubMed Web of Science ®Google Scholar
• Hokfelt T, Pernow B, Wahren J. Substance P: a pioneer amongst neuropeptides. J Intern Med 2001; 249: 27–40
   PubMed Web of Science ®Google Scholar
• Fernandez-Rodriguez CM, Prieto J, Quiroga J, Zozoya JM, Andrade A, Nunez M, et al. Plasma levels of substance P in liver cirrhosis: relationship to the activation of vasopressor systems and urinary sodium excretion. Hepatology 1995; 21: 35–40
   PubMed Web of Science ®Google Scholar
• Lee FY, Lin HC, Tsai YT, Chang FY, Lu RH, Hou MC, et al. Plasma substance P levels in patients with liver cirrhosis: relationship to systemic and portal hemodynamics. Am J Gastroenterol 1997; 92: 2080–4
   PubMed Web of Science ®Google Scholar
• Hortnagl H, Singer EA, Lenz K, Kleinberger G, Lochs H. Substance P is markedly increased in plasma of patients with hepatic coma. Lancet 1984; 1: 480–3
   PubMed Web of Science ®Google Scholar
• Jimenez W, Claria J, Arroyo V, Rodes J. Carbon tetrachloride induced cirrhosis in rats: a useful tool for investigating the pathogenesis of ascites in chronic liver disease. J Gastroenterol Hepatol 1992; 7: 90–7
   PubMed Web of Science ®Google Scholar
• Martin PY, Xu DL, Niederberger M, Weigert A, Tsai P, St John J, et al. Upregulation of endothelial constitutive NOS: a major role in the increased NO production in cirrhotic rats. Am J Physiol 1996; 270: F494–9
   Google Scholar
• Ros J, Jimenez W, Lamas S, Claria J, Arroyo V, Rivera F, et al. Nitric oxide production in arterial vessels of cirrhotic rats. Hepatology 1995; 21: 554–60
   PubMed Web of Science ®Google Scholar
• Sieber CC, Lopez-Talavera JC, Groszmann RJ. Role of nitric oxide in the in vitro splanchnic vascular hyporeactivity in ascitic cirrhotic rats. Gastroenterology 1993; 104: 1750–4
   PubMed Web of Science ®Google Scholar
• Niederberger M, Gines P, Tsai P, Martin PY, Morris K, Weigert A, et al. Increased aortic cyclic guanosine monophosphate concentration in experimental cirrhosis in rats: evidence for a role of nitric oxide in the pathogenesis of arterial vasodilation in cirrhosis. Hepatology 1995; 21: 1625–31
   PubMed Web of Science ®Google Scholar
• Arroyo V, Guevara M, Gines P. Hepatorenal syndrome in cirrhosis: pathogenesis and treatment. Gastroenterology 2002; 122: 1658–76
   PubMed Web of Science ®Google Scholar
• Goyal RK, Irano I. The enteric nervous system. N Engl J Med 1996; 334: 1106–15
   PubMed Web of Science ®Google Scholar
• Iwakiri Y, Groszmann R. The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule. Hepatology 2006; 43: S121–31
   PubMed Web of Science ®Google Scholar
• Wiest R, Garcia-Tsao R. Bacterial translocation (BT) in cirrhosis. Hepatology 2005; 41: 422–33
   PubMed Web of Science ®Google Scholar
• Petersson J, Zygmunt PM, Brandt L, Hogestatt ED. Substance P-induced relaxation and hyperpolarization in human cerebral arteries. Br J Pharmacol 1995; 115: 889–94
   PubMed Web of Science ®Google Scholar
• Ros J, Claria J, To-Figueras J, Planaguma A, Cejudo-Martin P, Fernandez-Varo G, et al. Endogenous cannabinoids: a new system involved in the homeostasis of arterial pressure in experimental cirrhosis in the rat. Gastroenterology 2002; 122: 85–93
   PubMed Web of Science ®Google Scholar
• Uemura M, Tsujii T, Kikuchi E, Fukui H, Tsukamoto N, Matsumura M, et al. Increased plasma levels of substance P and disturbed water excretion in patients with liver cirrhosis. Scand J Gastroenterol 1998; 33: 860–6
   PubMed Web of Science ®Google Scholar
• Chu CJ, Lee FY, Wang SS, Chang FY, Tsai YT, Lin HC, et al. Hyperdynamic circulation of cirrhotic rats: role of substance P and its relationship to nitric oxide. Scand J Gastroenterol 1997; 32: 841–6
   PubMed Web of Science ®Google Scholar